Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus–mechanisms …

CC Low Wang, CN Hess, WR Hiatt, AB Goldfine - Circulation, 2016 - Am Heart Assoc
Cardiovascular disease remains the principal cause of death and disability among patients
with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying …

Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection

M Vardi, NS Levy, AP Levy - Journal of lipid research, 2013 - ASBMB
Vitamin E is a naturally occurring fat-soluble antioxidant which has been proposed as a
treatment for both primary and secondary protection against cardiovascular (CV) events …

Learning from longitudinal data in electronic health record and genetic data to improve cardiovascular event prediction

J Zhao, QP Feng, P Wu, RA Lupu, RA Wilke… - Scientific reports, 2019 - nature.com
Current approaches to predicting a cardiovascular disease (CVD) event rely on
conventional risk factors and cross-sectional data. In this study, we applied machine …

[HTML][HTML] Is glucose control important for prevention of cardiovascular disease in diabetes?

E Mannucci, I Dicembrini, A Lauria, P Pozzilli - Diabetes care, 2013 - ncbi.nlm.nih.gov
Patients affected by diabetes show an increased risk of cardiovascular disease (CVD) and
mortality that reduces their life expectancy by 5–15 years (depending on the age at …

Repetitive intermittent hyperglycemia drives the M1 polarization and inflammatory responses in THP-1 macrophages through the mechanism involving the TLR4-IRF5 …

F Al-Rashed, S Sindhu, H Arefanian, A Al Madhoun… - Cells, 2020 - mdpi.com
Repetitive intermittent hyperglycemia (RIH) is an independent risk factor for complications
associated with type-2 diabetes (T2D). Glucose fluctuations commonly occur in T2D patients …

The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?

KE Porter, K Riches - Clinical science, 2013 - portlandpress.com
The rising epidemic of T2DM (Type 2 diabetes mellitus) worldwide is of significant concern.
The inherently silent nature of the disease in its early stages precludes early detection; …

Fasting plasma glucose and subsequent cardiovascular disease among young adults: analysis of a nationwide epidemiological database

H Kaneko, H Itoh, H Kiriyama, T Kamon, K Fujiu… - Atherosclerosis, 2021 - Elsevier
Background and aims Using a nationwide epidemiological database, we aimed to clarify the
association of fasting plasma glucose (FPG) with subsequent cardiovascular disease (CVD) …

[HTML][HTML] Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes–mechanisms, management, and clinical considerations

CCL Wang, CN Hess, WR Hiatt, AB Goldfine - Circulation, 2016 - ncbi.nlm.nih.gov
Cardiovascular disease remains the principal cause of death and disability among patients
with diabetes mellitus. Diabetes exacerbates mechanisms underlying atherosclerosis and …

Post-prandial effects of high-polyphenolic extra virgin olive oil on endothelial function in adults at risk for type 2 diabetes: A randomized controlled crossover trial

VY Njike, R Ayettey, JA Treu, KN Doughty… - International journal of …, 2021 - Elsevier
Background Effects of olive oil on cardiovascular risk have been controversial. We
compared the effects of high-polyphenolic extra virgin olive oil (EVOO) and refined olive oil …

Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival

CCL Wang, JEB Reusch - The American journal of cardiology, 2012 - Elsevier
Diabetes mellitus (DM) is the fifth-leading cause of death worldwide and contributes to
leading causes of death, cancer and cardiovascular disease, including CAD, stroke …